Rachid Benrkia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rachid Benrkia has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Opeyemi Joshua Olatunji
African Genome Center, Mohammed VI Polytechnic University, Ben Guerir, Morocco
3 shared publications Chitchamai Ovatlarnporn
Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences
2 shared publicationsOlusola Emmanuel Idowu
2 shared publicationsSalima Boutahiri
2 shared publications- Alvin Elikplim Fianu
African Genome Center, University Mohammed VI Polytechnic (UM6P), Lot 660, Hay Moulay Rachid, Ben Guerir 43150, Morocco
1 shared publication Babalwa Tembeni
1 shared publication
Latest Publications
- 25 August 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (35) , 21728-21753
Mediterranean Seaweeds: Bridging Chemistry Knowledge, Microbial Community Profiling, Therapeutic, Nutraceutical, and Industrial Applications
Mediterranean seaweeds are a valuable source of bioactive compounds that evolved in response to the region's unique conditions. These compounds, initially serving defensive roles, show strong pharmaceutical potential with antimicrobial, antioxidant, anti-inflammatory, antiviral, and anticancer properties. Rich in polysaccharides, polyphenols, and essential fatty acids, these macroalgae are increasingly recognized for their role in functional foods and nutraceuticals. However, research gaps persist, especially in chemical characterization and microbial profiling. The diversity, ecological roles, metabolic capabilities, and nutraceutical potential of the associated microorganisms are still poorly understood. This review offers an overview of the chemical and microbial profiling of Mediterranean seaweeds, emphasizing their pharmacological and nutraceutical value. It highlights the role of symbiotic microorganisms in metabolite biosynthesis and explores strategies to enhance the production of bioactive compounds. By doing so, this review aims to unlock the full potential of Mediterranean seaweeds and their microbial partners for sustainable pharmaceutical, nutraceutical, and industrial applications.
- 25 August 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (35) , 21728-21753
Mediterranean Seaweeds: Bridging Chemistry Knowledge, Microbial Community Profiling, Therapeutic, Nutraceutical, and Industrial Applications
Mediterranean seaweeds are a valuable source of bioactive compounds that evolved in response to the region's unique conditions. These compounds, initially serving defensive roles, show strong pharmaceutical potential with antimicrobial, antioxidant, anti-inflammatory, antiviral, and anticancer properties. Rich in polysaccharides, polyphenols, and essential fatty acids, these macroalgae are increasingly recognized for their role in functional foods and nutraceuticals. However, research gaps persist, especially in chemical characterization and microbial profiling. The diversity, ecological roles, metabolic capabilities, and nutraceutical potential of the associated microorganisms are still poorly understood. This review offers an overview of the chemical and microbial profiling of Mediterranean seaweeds, emphasizing their pharmacological and nutraceutical value. It highlights the role of symbiotic microorganisms in metabolite biosynthesis and explores strategies to enhance the production of bioactive compounds. By doing so, this review aims to unlock the full potential of Mediterranean seaweeds and their microbial partners for sustainable pharmaceutical, nutraceutical, and industrial applications.
- 12 April 2025
- Published by Elsevier in Fitoterapia
- Vol. 183, 106542
Unveiling the mystery of the genus Tiliacora: A holistic view on the ethnomedicinal uses, phytochemical richness and pharmacological potentials
- 12 April 2025
- Published by Elsevier in Fitoterapia
- Vol. 183, 106542
Unveiling the mystery of the genus Tiliacora: A holistic view on the ethnomedicinal uses, phytochemical richness and pharmacological potentials
- 19 February 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 179, 179-187
Novel insight into the potential of flavonol-enriched extracts from saffron (Crocus sativus L.) floral bio-residues as source of antioxidants agents
- 19 February 2025
- Published by Elsevier in South African Journal of Botany
- Vol. 179, 179-187
Novel insight into the potential of flavonol-enriched extracts from saffron (Crocus sativus L.) floral bio-residues as source of antioxidants agents
- Top Cited PapersOpen Access
- 1 November 2024
- Published by Elsevier in Current Plant Biology
- Vol. 40
Effect of biostimulants on the chemical profile of food crops under normal and abiotic stress conditions
- 1 November 2024
- Published by Elsevier in Current Plant Biology
- Vol. 40
Top Cited PapersOpen AccessEffect of biostimulants on the chemical profile of food crops under normal and abiotic stress conditions
- Open Access
- 19 August 2024
- Published by Springer Nature in Natural Products and Bioprospecting
- Vol. 14 (1) , 1-30
Biotransformation of selected secondary metabolites by Alternaria species and the pharmaceutical, food and agricultural application of biotransformation products
Biotransformation is a process in which molecules are modified in the presence of a biocatalyst or enzymes, as well as the metabolic alterations that occur in organisms from exposure to the molecules. Microbial biotransformation is an important process in natural product drug discovery as novel compounds are biosynthesised. Additionally, biotransformation products offer compounds with improved efficacy, solubility, reduced cytotoxic and allows for the understanding of structure activity relationships. One of the driving forces for these impeccable findings are associated with the presence of cytochrome P450 monooxygenases that is present in all organisms such as mammals, bacteria, and fungi. Numerous fungal strains have been used and reported for their ability to biotransform different compounds. This review focused on studies using Alternaria species as biocatalysts in the biotransformation of natural product compounds. Alternaria species facilitates reactions that favour stereoselectivity, regioselectivity under mild conditions. Additionally, microbial biotransformation products, their application in food, pharmaceutical and agricultural sector is discussed in this review. Graphical Abstract
- 19 August 2024
- Published by Springer Nature in Natural Products and Bioprospecting
- Vol. 14 (1) , 1-30
Open AccessBiotransformation of selected secondary metabolites by Alternaria species and the pharmaceutical, food and agricultural application of biotransformation products
Biotransformation is a process in which molecules are modified in the presence of a biocatalyst or enzymes, as well as the metabolic alterations that occur in organisms from exposure to the molecules. Microbial biotransformation is an important process in natural product drug discovery as novel compounds are biosynthesised. Additionally, biotransformation products offer compounds with improved efficacy, solubility, reduced cytotoxic and allows for the understanding of structure activity relationships. One of the driving forces for these impeccable findings are associated with the presence of cytochrome P450 monooxygenases that is present in all organisms such as mammals, bacteria, and fungi. Numerous fungal strains have been used and reported for their ability to biotransform different compounds. This review focused on studies using Alternaria species as biocatalysts in the biotransformation of natural product compounds. Alternaria species facilitates reactions that favour stereoselectivity, regioselectivity under mild conditions. Additionally, microbial biotransformation products, their application in food, pharmaceutical and agricultural sector is discussed in this review. Graphical Abstract